ClinicalTrials.Veeva

Menu

External Facilitation to Increase Prescribing of AUD Medications in the Psychiatric Setting

University of Maryland Baltimore (UMB) logo

University of Maryland Baltimore (UMB)

Status

Enrolling

Conditions

Psychiatric Disorder
Alcohol-Related Disorders

Treatments

Other: Implementation Facilitation

Study type

Interventional

Funder types

Other

Identifiers

NCT07053098
1R34AA032051-01 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

This project will pilot test an implementation facilitation intervention to increase prescribing of medications for alcohol use disorder (MAUD) in patients with major mental illness and alcohol use disorder in three psychiatry treatment clinics.

Full description

This project will pilot test an implementation facilitation intervention to increase prescribing of medications for alcohol use disorder (MAUD) in patients with major mental illness and alcohol use disorder in three psychiatry treatment clinics. Guided by the integrated Promoting Action on Research Implementation in Health Services framework, an external facilitator will work with each clinics' internal champion to (1) provide clinic level education on MAUD in non-specialty care settings, (2) provide clinic level training in using a standardized screen measure for alcohol use disorder, documenting screening results in the electronic health record, and documenting alcohol use disorder diagnosis in the electronic health record, (3) help internal champions use an audit and feedback system for weekly review of MAUD education and prescribing, (4) help internal champions do weekly care coordination for patients with major mental illness and alcohol use disorder, and (5) make educational materials on MAUD available on site to patients so they are informed about these treatment options. Internal champions and clinics will have access to consultation from a MAUD clinician expert. These activities will take place across pre-implementation and implementation phases and will be followed by a post-implementation facilitation sustainment period during which clinics and champions continue implementation on their own. Formative Evaluation activities will take place throughout; at the end of the sustainment phase, MAUD outcomes will be assessed.

Enrollment

40 estimated patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • For prescribers: working as a prescriber, non-prescribing clinician, or administrator at one of the three participating clinics.
  • For patients: has major mental illness (major depressive disorders, bipolar disorder, schizophrenia spectrum disorders, other psychotic disorders; posttraumatic stress disorder)
  • For patients: has Alcohol Use Disorder and is being treated in one of the three participating clinics.

Exclusion criteria

  • For all: age is less than 18 years old
  • For all: not able to complete informed consent

Trial design

Primary purpose

Health Services Research

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

40 participants in 1 patient group

Implementation Facilitation
Experimental group
Description:
This Implementation Facilitation Intervention will include external facilitation, staff training, patient education, audit and feedback, and care coordination.
Treatment:
Other: Implementation Facilitation

Trial contacts and locations

1

Loading...

Central trial contact

Melanie Bennett, PhD; Brian Brandler

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems